IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 212 filers reported holding IMMUNOMEDICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,586,000 | +1013.7% | 42,172 | +363.6% | 0.02% | +666.7% |
| Q2 2020 | $322,000 | -45.3% | 9,097 | -79.2% | 0.00% | -50.0% |
| Q1 2020 | $589,000 | +115.8% | 43,700 | +238.3% | 0.01% | +200.0% |
| Q4 2019 | $273,000 | +137.4% | 12,918 | +49.3% | 0.00% | +100.0% |
| Q3 2019 | $115,000 | +12.7% | 8,655 | +18.0% | 0.00% | 0.0% |
| Q2 2019 | $102,000 | -36.6% | 7,336 | -12.4% | 0.00% | 0.0% |
| Q1 2019 | $161,000 | -50.2% | 8,373 | -63.0% | 0.00% | -66.7% |
| Q4 2018 | $323,000 | +90.0% | 22,638 | +215.7% | 0.00% | +50.0% |
| Q2 2018 | $170,000 | +68.3% | 7,171 | +4.2% | 0.00% | +100.0% |
| Q1 2018 | $101,000 | -43.9% | 6,882 | -38.4% | 0.00% | -50.0% |
| Q4 2017 | $180,000 | -51.1% | 11,164 | -57.6% | 0.00% | -33.3% |
| Q3 2017 | $368,000 | +101.1% | 26,350 | +27.2% | 0.00% | +50.0% |
| Q2 2017 | $183,000 | +173.1% | 20,719 | +99.3% | 0.00% | +100.0% |
| Q1 2017 | $67,000 | -55.3% | 10,396 | -74.6% | 0.00% | 0.0% |
| Q4 2016 | $150,000 | +275.0% | 40,919 | +236.1% | 0.00% | – |
| Q3 2016 | $40,000 | -43.7% | 12,175 | -57.0% | 0.00% | -100.0% |
| Q1 2016 | $71,000 | +77.5% | 28,315 | +173.8% | 0.00% | – |
| Q1 2015 | $40,000 | -35.5% | 10,343 | -20.3% | 0.00% | – |
| Q4 2014 | $62,000 | -24.4% | 12,974 | -1.6% | 0.00% | – |
| Q3 2013 | $82,000 | – | 13,186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |